Predictors and changes of physical activity in idiopathic pulmonary fibrosis.
Depression
Idiopathic pulmonary fibrosis
Muscle strength
Physical activity
Predictors
Prognosis
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
09 Sep 2022
09 Sep 2022
Historique:
received:
03
05
2022
accepted:
22
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
Different clinical predictors of physical activity (PA) have been described in idiopathic pulmonary fibrosis (IPF), but studies are lacking evaluating the potential role of muscle strength and anxiety and depression symptoms in PA limitation. Moreover, little is known about the impact of changes in PA in the course of the disease. The aim of the present study was to investigate the relationship between baseline PA and a wide range of variables in IPF, to assess its longitudinal changes at 12 months and its impact on progression free-survival. PA was assessed by accelerometer and physiological, clinical, psychological factors and health-related quality of life were evaluated in subjects with IPF at baseline and at 12 month follow-up. Predictors of PA were determined at baseline, evolution of PA parameters was described and the prognostic role of PA evolution was also established. Forty participants with IPF were included and 22 completed the follow-up. At baseline, subjects performed 5765 (3442) daily steps and spent 64 (44) minutes/day in moderate to vigorous PA. Multivariate regression models showed that at baseline, a lower six-minute walked distance, lower quadriceps strength (QMVC), and a higher depression score in the Hospital Anxiety and Depression scale were associated to lower daily step number. In addition, being in (Gender-Age-Physiology) GAP III stage, having a BMI ≥ 25 kg/m Among a wide range of variables, muscle strength and depression symptoms have a predominant role in PA in IPF patients. Daily PA behaviour and its evolution should be considered in IPF clinical assessment and as a potential complementary indicator of disease prognosis.
Sections du résumé
BACKGROUND
BACKGROUND
Different clinical predictors of physical activity (PA) have been described in idiopathic pulmonary fibrosis (IPF), but studies are lacking evaluating the potential role of muscle strength and anxiety and depression symptoms in PA limitation. Moreover, little is known about the impact of changes in PA in the course of the disease. The aim of the present study was to investigate the relationship between baseline PA and a wide range of variables in IPF, to assess its longitudinal changes at 12 months and its impact on progression free-survival.
METHODS
METHODS
PA was assessed by accelerometer and physiological, clinical, psychological factors and health-related quality of life were evaluated in subjects with IPF at baseline and at 12 month follow-up. Predictors of PA were determined at baseline, evolution of PA parameters was described and the prognostic role of PA evolution was also established.
RESULTS
RESULTS
Forty participants with IPF were included and 22 completed the follow-up. At baseline, subjects performed 5765 (3442) daily steps and spent 64 (44) minutes/day in moderate to vigorous PA. Multivariate regression models showed that at baseline, a lower six-minute walked distance, lower quadriceps strength (QMVC), and a higher depression score in the Hospital Anxiety and Depression scale were associated to lower daily step number. In addition, being in (Gender-Age-Physiology) GAP III stage, having a BMI ≥ 25 kg/m
CONCLUSION
CONCLUSIONS
Among a wide range of variables, muscle strength and depression symptoms have a predominant role in PA in IPF patients. Daily PA behaviour and its evolution should be considered in IPF clinical assessment and as a potential complementary indicator of disease prognosis.
Identifiants
pubmed: 36085057
doi: 10.1186/s12890-022-02134-4
pii: 10.1186/s12890-022-02134-4
pmc: PMC9461180
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
340Subventions
Organisme : Instituto de Salud Carlos III
ID : Rio Hortega
Informations de copyright
© 2022. The Author(s).
Références
Eur Respir J. 2009 Feb;33(2):262-72
pubmed: 19010994
Multidiscip Respir Med. 2010 Jun 30;5(3):211-5
pubmed: 22958444
Lung. 2019 Feb;197(1):37-45
pubmed: 30430249
Thorax. 1999 Jul;54(7):581-6
pubmed: 10377201
Respirology. 2015 May;20(4):640-6
pubmed: 25728219
Respiration. 2016;91(6):497-502
pubmed: 27240427
BMC Pulm Med. 2019 Oct 21;19(1):183
pubmed: 31638951
BMJ Open Respir Res. 2017 Sep 17;4(1):e000212
pubmed: 29018526
Respir Med. 2019 May;151:81-95
pubmed: 31047122
Chron Respir Dis. 2016 May;13(2):162-72
pubmed: 26768011
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Eur Respir Rev. 2018 Dec 21;27(150):
pubmed: 30578335
Thorax. 1980 Feb;35(2):92-100
pubmed: 7376125
Respiration. 2021;100(12):1151-1157
pubmed: 34247176
Lung. 2019 Aug;197(4):415-425
pubmed: 31154459
Chest. 2005 Jun;127(6):2028-33
pubmed: 15947316
Int J Chron Obstruct Pulmon Dis. 2016 Jun 10;11:1287-95
pubmed: 27354787
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Eur Respir J. 2005 Oct;26(4):720-35
pubmed: 16204605
Respir Med. 1991 Sep;85 Suppl B:25-31; discussion 33-7
pubmed: 1759018
Respirology. 2021 Dec;26(12):1152-1159
pubmed: 34448321
Clin Nutr. 2005 Apr;24(2):250-8
pubmed: 15784486
Respir Res. 2019 Mar 12;20(1):56
pubmed: 30866948
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Clin Chest Med. 2019 Jun;40(2):405-420
pubmed: 31078218
BMC Pulm Med. 2017 Jul 25;17(1):104
pubmed: 28743305
Chest. 2011 Aug;140(2):331-342
pubmed: 21273294
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Respir Investig. 2018 Jan;56(1):57-63
pubmed: 29325683
Am J Respir Crit Care Med. 1996 Mar;153(3):976-80
pubmed: 8630582
J Cardiopulm Rehabil Prev. 2011 Jan-Feb;31(1):11-24
pubmed: 20724932
J Appl Physiol (1985). 2013 May;114(9):1222-34
pubmed: 23519228
Arch Bronconeumol. 1997 May;33(5):213-9
pubmed: 9254166
Med Sci Sports Exerc. 2007 Aug;39(8):1423-34
pubmed: 17762377
Chest. 2013 Nov;144(5):1652-1658
pubmed: 23928896